SHOULDER INNOVATIONS, INC. Operating Cash Flow
SHOULDER INNOVATIONS, INC. (SI) reported Operating Cash Flow of -$19.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.39M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$12.36M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$8.78M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.55M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$28.61M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$14.14M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$19.75M 10-Q · filed 2026-08-06 | -$28.53M derived: sum of 3 quarters · filed 2026-08-06 | -$37.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$12.36M 10-Q · filed 2026-05-13 | -$21.14M derived: sum of 2 quarters · filed 2026-05-13 | -$29.70M derived: sum of 3 quarters · filed 2026-05-13 | -$34.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$17.34M derived: sum of 2 quarters · filed 2026-03-10 | -$22.14M derived: sum of 3 quarters · filed 2026-08-06 | -$28.61M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$13.35M derived: sum of 2 quarters · filed 2026-08-06 | -$19.83M 10-Q · filed 2025-11-12 | -$23.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$11.27M 10-Q · filed 2026-08-06 | -$14.55M derived: sum of 3 quarters · filed 2026-08-06 | -$19.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$6.48M 10-Q · filed 2026-05-13 | -$9.75M derived: sum of 2 quarters · filed 2026-05-13 | -$14.64M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$8.16M derived: sum of 2 quarters · filed 2026-03-10 | -$14.14M 10-K · filed 2026-03-10 | |
| 2024-09-30 | -$4.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$10.87M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$5.98M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |